Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

SR-18292 Induces Fetal Hemoglobin Synthesis and Reduces Disease Pathology in Sickle Cell Mice

Yanan Sun, Hajar Benmhammed, Alawi Habara, Martin H. Steinberg, Shuaiying Cui

Blood (2023) 142 (Supplement 1): 5258.

https://doi.org/10.1182/blood-2023-186314

Published: 2023

Journal Articles

Targeting Transcriptional Co-Activator PGC-1a for the Treatment of Sickle Cell Disease

Alawi Habara, MBBS, MSc, Cuong LE, PhD, David H.K. Chui, MD, Martin H. Steinberg, MD, Shuaiying Cui, PhD

Blood (2019) 134 (Supplement_1): 2254.

https://doi.org/10.1182/blood-2019-123959

Published: 2019

Journal Articles

Inhibition of LSD1 by small molecule inhibitors stimulates fetal hemoglobin synthesis

Cuong Quang Le, Greggory Myers, Alawi Habara, Natee Jearawiriyapaisarn, George J. Murphy, David H. K. Chui, Martin H. Steinberg, James Douglas Engel, Shuaiying Cui

Blood (2019) 133 (22): 2455–2459.

https://doi.org/10.1182/blood.2018892737

Published: 2019

Includes: Supplemental data

Journal Articles

Regulating Transcriptional Co-Activator PGC-1α for the Treatment of Sickle Cell Disease

Alawi Habara, MBBS, MSc, Cuong LE, PhD, George J Murphy, PhD, David H.K. Chui, MD, Martin H. Steinberg, MD, Shuaiying Cui, PhD

Blood (2018) 132 (Supplement 1): 2358.

https://doi.org/10.1182/blood-2018-99-111022

Published: 2018

Journal Articles

LSD1 Inhibitors Induce Fetal Hemoglobin in Primary Human Erythroid Cells

Cuong LE, PhD, Greggory Myers, Alawi Habara, MBBS, MSc, David H.K. Chui, MD, Martin H. Steinberg, MD, James Douglas Engel, PhD, Shuaiying Cui, PhD

Blood (2018) 132 (Supplement 1): 1066.

https://doi.org/10.1182/blood-2018-99-117675

Published: 2018

Journal Articles

In Vivo Effects of LSD1 Inhibition By Small Chemical Inhibitors in Sickle Cell Mice

Cuong Le, PhD, Greggory Myers, Alawi Habara, Natee Jearawiriyapaisarn, PhD, Mary Lee, PhD, David H.K. Chui, MD, Martin H. Steinberg, MD, James Engel, PhD, Shuaiying Cui, PhD

Blood (2017) 130 (Supplement 1): 968.

https://doi.org/10.1182/blood.V130.Suppl_1.968.968

Published: 2017

NARROW

SR-18292 Induces Fetal Hemoglobin Synthesis and Reduces Disease Pathology in Sickle Cell Mice

Targeting Transcriptional Co-Activator PGC-1a for the Treatment of Sickle Cell Disease

Inhibition of LSD1 by small molecule inhibitors stimulates fetal hemoglobin synthesis

Regulating Transcriptional Co-Activator PGC-1α for the Treatment of Sickle Cell Disease

LSD1 Inhibitors Induce Fetal Hemoglobin in Primary Human Erythroid Cells

In Vivo Effects of LSD1 Inhibition By Small Chemical Inhibitors in Sickle Cell Mice

Email alerts

ASH Publications

American Society of Hematology

SR-18292 Induces Fetal Hemoglobin Synthesis and Reduces Disease Pathology in Sickle Cell Mice

Targeting Transcriptional Co-Activator PGC-1a for the Treatment of Sickle Cell Disease

Inhibition of LSD1 by small molecule inhibitors stimulates fetal hemoglobin synthesis

Regulating Transcriptional Co-Activator PGC-1α for the Treatment of Sickle Cell Disease

LSD1 Inhibitors Induce Fetal Hemoglobin in Primary Human Erythroid Cells

In Vivo Effects of LSD1 Inhibition By Small Chemical Inhibitors in Sickle Cell Mice

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only